6.15 USD
+0.22 (+3.71%)
6.18 USD
+0.03 (+0.49%)
ChartMill assigns a Buy % Consensus number of 84% to AQST. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.51. This target is 70.83% above the current price.
AQST was analyzed by 16 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about AQST.
In the previous month the buy percentage consensus was at a similar level.
AQST was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-09 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-09-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-06-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-07 | Lake Street | Maintains | Buy -> Buy |
| 2024-12-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-17 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-25 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-10-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-08 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-30 | Leerink Partners | Reiterate | Outperform -> Outperform |
| 2024-09-30 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-07-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-26 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-10 | Leerink Partners | Initiate | Outperform |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-11 | Piper Sandler | Initiate | Overweight |
| 2024-04-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-28 | Raymond James | Initiate | Outperform |
| 2024-03-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
AQUESTIVE THERAPEUTICS INC / AQST FAQ
Can you provide the average price target for AQUESTIVE THERAPEUTICS INC stock?
16 analysts have analysed AQST and the average price target is 10.51 USD. This implies a price increase of 70.83% is expected in the next year compared to the current price of 6.15.
How do analysts rate AQUESTIVE THERAPEUTICS INC (AQST)?
The consensus rating for AQUESTIVE THERAPEUTICS INC (AQST) is 83.75 / 100 . This indicates that analysts generally have a positive outlook on the stock.